Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G E Zurenko

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Anaerobe|August 5, 2006
In vitro activity of linezolid and eperezolid, two novel oxazolidinone antimicrobial agents, against anaerobic bacteriaB H Yagi, G E Zurenko
Diagnostic Microbiology and Infectious Disease|November 1, 1993
Prediction of bacterial susceptibility to cefpodoxime by using the ceftriaxone minimum inhibitory concentration resultR N Jones, G E Zurenko
Diagnostic Microbiology and Infectious Disease|February 1, 1992
Modification of the error-rate bounded classification scheme for use with two MIC break pointsM N Brunden, G E Zurenko, B Kapik
Journal of Medicinal Chemistry|September 1, 1984
Benzisoxazolones: antimicrobial and antileukemic activityW Wierenga, B R Evans, G E Zurenko
Drugs Under Experimental and Clinical Research|January 1, 1988
Trospectomycin, a novel spectinomycin analogue: antibacterial activity and preliminary human pharmacokineticsG E Zurenko, C W Ford, E Novak
Diagnostic Microbiology and Infectious Disease|July 1, 1992
The bactericidal activity and postantibiotic effect of trospectomycinB H Yagi, R D Schaadt, G E Zurenko
Antimicrobial Agents and Chemotherapy|February 1, 1990
In vitro activity of cefpodoxime proxetil (U-76,252; CS-807) against Neisseria gonorrhoeaeR D Schaadt, B H Yagi, G E Zurenko
The Journal of Antimicrobial Chemotherapy|April 1, 1989
Interaction of cephalosporins with penicillin-binding proteins of methicillin-resistant Staphylococcus aureusS E Truesdell, G E Zurenko, A L Laborde
Current Drug Targets. Infectious Disorders|November 29, 2002
The discovery of linezolid, the first oxazolidinone antibacterial agentC W Ford, G E Zurenko, M R Barbachyn
Antimicrobial Agents and Chemotherapy|February 1, 1988
In vitro antibacterial activity of trospectomycin (U-63366F), a novel spectinomycin analogG E Zurenko, B H Yagi, J J Vavra, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Anaerobe|August 5, 2006
In vitro activity of linezolid and eperezolid, two novel oxazolidinone antimicrobial agents, against anaerobic bacteriaB H Yagi, G E Zurenko
Diagnostic Microbiology and Infectious Disease|November 1, 1993
Prediction of bacterial susceptibility to cefpodoxime by using the ceftriaxone minimum inhibitory concentration resultR N Jones, G E Zurenko
Diagnostic Microbiology and Infectious Disease|February 1, 1992
Modification of the error-rate bounded classification scheme for use with two MIC break pointsM N Brunden, G E Zurenko, B Kapik
Journal of Medicinal Chemistry|September 1, 1984
Benzisoxazolones: antimicrobial and antileukemic activityW Wierenga, B R Evans, G E Zurenko
Drugs Under Experimental and Clinical Research|January 1, 1988
Trospectomycin, a novel spectinomycin analogue: antibacterial activity and preliminary human pharmacokineticsG E Zurenko, C W Ford, E Novak
Diagnostic Microbiology and Infectious Disease|July 1, 1992
The bactericidal activity and postantibiotic effect of trospectomycinB H Yagi, R D Schaadt, G E Zurenko
Antimicrobial Agents and Chemotherapy|February 1, 1990
In vitro activity of cefpodoxime proxetil (U-76,252; CS-807) against Neisseria gonorrhoeaeR D Schaadt, B H Yagi, G E Zurenko
The Journal of Antimicrobial Chemotherapy|April 1, 1989
Interaction of cephalosporins with penicillin-binding proteins of methicillin-resistant Staphylococcus aureusS E Truesdell, G E Zurenko, A L Laborde
Current Drug Targets. Infectious Disorders|November 29, 2002
The discovery of linezolid, the first oxazolidinone antibacterial agentC W Ford, G E Zurenko, M R Barbachyn
Antimicrobial Agents and Chemotherapy|February 1, 1988
In vitro antibacterial activity of trospectomycin (U-63366F), a novel spectinomycin analogG E Zurenko, B H Yagi, J J Vavra, et al.
Pageof 4